- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06. | Envoy Medical, Inc.: Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th | 291 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) - Envoy Medical Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced that Brent... ► Artikel lesen | |
| ENVOY MEDICAL Aktie jetzt für 0€ handeln | |||||
| 02.06. | Envoy Medical Signs Multi-Part Series With New to The Street | 229 | ACCESS Newswire | Envoy Medical to Launch National Media Awareness Campaign Highlighting a Global Hearing-Loss Market Affecting More Than 1.5 Billion People Worldwide NEW YORK CITY, NY / ACCESS Newswire / June 2, 2026... ► Artikel lesen | |
| 20.05. | Envoy Medical, Inc.: Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology | 213 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - May 20, 2026) - Envoy Medical Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance... ► Artikel lesen | |
| 18.05. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Envoy Medical GAAP EPS of -$0.08, revenue of $0.03M | 2 | Seeking Alpha | ||
| 11.05. | Envoy Medical, Inc.: Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant | 336 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - May 11, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| 11.05. | Envoy Medical, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Envoy Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.04. | Envoy Medical presents early data from cochlear implant trial | 3 | Investing.com | ||
| 28.04. | Envoy Medical, Inc.: Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant | 477 | Newsfile | Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Quality of Life Scores Presented; Additional Presentations Scheduled in Early MayDetails to be Discussed... ► Artikel lesen | |
| 22.04. | Envoy Medical, Inc.: Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant | 280 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 21.04. | Envoy Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.04. | Envoy Medical, Inc.: Envoy Medical Appoints Chas McKhann to Board of Directors | 304 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today... ► Artikel lesen | |
| 13.04. | Envoy Medical, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 01.04. | Envoy Medical, Inc.: Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant | 311 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, announced... ► Artikel lesen | |
| 27.03. | Envoy Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.03. | Envoy Medical GAAP EPS of -$1.23, revenue of $0.02M | 1 | Seeking Alpha | ||
| 23.03. | Envoy Medical, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 23.03. | Envoy Medical, Inc.: Envoy Medical Reports Full Year 2025 Financial Results | 688 | Newsfile | Received FDA approval to expand fully implanted Acclaim Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end... ► Artikel lesen | |
| 11.03. | Envoy Medical, Inc.: Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant | 401 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - March 11, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen |
1 2 3 4 Weiter >>
69 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,690 | +1,40 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
04.06.2026 /... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,560 | 0,00 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| SIEMENS HEALTHINEERS | 35,100 | +0,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,830 | +0,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,60 | +0,02 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| HEARTFLOW | 29,430 | 0,00 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| BILLIONTOONE | 98,92 | -0,34 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 54,36 | +0,07 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| PROGYNY | 25,880 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| CARL ZEISS MEDITEC | 25,700 | -0,31 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,905 | +0,02 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| BETA BIONICS | 13,720 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,100 | +0,03 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 7,860 | 0,00 % | Goldman Sachs initiates Lifestance Health stock at neutral | ||
| GERRESHEIMER | 24,660 | -0,16 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
05.06.2026 / 16:28 CET/CEST
Veröffentlichung... ► Artikel lesen |
Das Unternehmen ENVOY MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,22 % bei einem Aktienkurs von 0,663 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVOY MEDICAL INC finden Sie auf Wallstreet Online.